Bezos paid $3 billion hoping to live longer | Benzinga Spain

3 min reading

Rejuvenation is no longer just something for the human face, but possibly for the human race, according to a small biotech company that claims to have developed technology that extends the lives of mice by 7%.

Although the trailer has not been peer-reviewed, Rejuvenate Organicwhich is based in San Diego, claims that it has succeeded in reprogramming the genes of small rodents, allowing these mice to live 18 weeks longer on average (after treatment) than the control group, according to data from MIT Technology Review.

What it means for humans

Vittorio Sebastianoteacher of the standford university, advised against testing the technology on humans. However, the scientific director of Rejuvenate Bio, noah davidsohnconsiders that there is a possible use for older people.

You might also be interested in: 20 valuable phrases from Jeff Bezos

“It is a powerful technology, and here is the proof of concept,” Davidsohn stated according to the report, adding that he “wanted to show that it is actually something that we can do in our older population.”

Rejuvenate Bio isn’t the only biotech company trying to find a cure for death. The founder of Amazon.com, Inc. (NASDAQ:AMZN), Jeff Bezosmade a $3 billion investment in the biotech startup High Labs a year ago, according to Popular Mechanics. Like Rejuvenate Bio, Altos is working to use cell rejuvenation to reverse disease and ultimately aging.

What is worrying

Beyond the physical concerns of testing the technology in humans, which has been shown to cause cancer in mice, the cost for humans to gain access to an FDA-approved cell rejuvenation, if it ever got that far, would be high.

That could mean that only the richest people in the world could afford to prolong their lives, giving the rich another shot at getting richer, who would accumulate their wealth for whatever extra lifetime they got. While the truth is that there is already a long-term gender gap among the wealthy, Christopher Warehambioethicist of the utrecht universityhe worries that the gap between rich and poor could widen if science confirms methods capable of extending the life of humans.

“Suppose, for example, we had some kind of vaccine for the age pandemic,” Wareham noted, according to the Financial Times. “This is going to potentially exacerbate all kinds of existing inequalities that we have… The longer you live, the more wealth you will accumulate, and the richer you are, the more political influence you will have.”

Larry Page Y sergey brinco-founders of Alphabet, Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL), as well as businessman yuri milner of Israel, are some of the mega-rich believers in science who are funding research on human longevity.

You might also be interested in: Should layoffs at Goldman, Amazon, or Salesforce worry you?

Image: Shutterstock